| 0 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
6 |
0.0001 |
| 1 |
Protease Inhibitor [EPC] |
4 |
0.0001 |
| 2 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2 |
0.0001 |
| 3 |
P2Y12 Platelet Inhibitor [EPC] |
9 |
0.0001 |
| 4 |
Cytochrome P450 3A Inhibitor [EPC] |
4 |
0.0001 |
| 5 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
6 |
0.0001 |
| 6 |
Vitamin D3 Analog [EPC] |
1 |
0.0000 |
| 7 |
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 8 |
Human Immunoglobulin G [EPC] |
1 |
0.0000 |
| 9 |
Factor Xa Inhibitor [EPC] |
9 |
0.0000 |
| 10 |
Purine Antimetabolite [EPC] |
2 |
0.0000 |
| 11 |
Central alpha-2 Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 12 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
1 |
0.0000 |
| 13 |
Aldosterone Antagonist [EPC] |
2 |
0.0000 |
| 14 |
Janus Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 15 |
Platelet Aggregation Inhibitor [EPC] |
7 |
0.0000 |
| 16 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 17 |
Antiarrhythmic [EPC] |
1 |
0.0000 |
| 18 |
Thiazide Diuretic [EPC] |
2 |
0.0000 |
| 19 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
1 |
0.0000 |
| 20 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 21 |
Calcium [EPC] |
1 |
0.0000 |
| 22 |
Loop Diuretic [EPC] |
3 |
0.0000 |
| 23 |
CD20-directed Cytolytic Antibody [EPC] |
2 |
0.0000 |
| 24 |
Angiotensin 2 Receptor Blocker [EPC] |
2 |
0.0000 |
| 25 |
Xanthine Oxidase Inhibitor [EPC] |
1 |
0.0000 |
| 26 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 27 |
Estrogen [EPC] |
1 |
0.0000 |
| 28 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
7 |
0.0000 |
| 29 |
Expectorant [EPC] |
1 |
0.0000 |
| 30 |
Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 31 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 32 |
Corticosteroid [EPC] |
4 |
0.0000 |
| 33 |
Dihydropyridine Calcium Channel Blocker [EPC] |
1 |
0.0000 |
| 34 |
Benzodiazepine [EPC] |
2 |
0.0000 |
| 35 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 36 |
Insulin Analog [EPC] |
1 |
0.0000 |
| 37 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1 |
0.0000 |
| 38 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |